Large Meta-Analysis Finds No Link Between ARBs and MI Risk

Angiotensin-receptor blockers (ARBs) don't increase the risk for MI, according to a large new meta-analysis published in BMJ. Concerns about ARBs and ...

To continue reading, please log in to the right or request an invitation.